NANOREPRO AGNN

NANOREPRO AG

1.305EURD
+0.005+0.38%
At close at May 23, 15:37 GMT
EUR
No trades
See on Supercharts

NN6 fundamentals

Key facts

Market capitalization‪17.36 M‬EUR
Founded1992
CEOLisa Jüngst
Websitenano.ag
About

NanoRepro AG engages in the development, manufacture, and distribution of diagnostic tests and food supplements for home and professional use. The firm operates through In-Vitro diagnostics for home and professional use, and Food supplements segments. It distributes its products under the AllergoCHECK, MilkCHECK, EggCHECK, FertiQUICK, OvuQUICK, GraviQUICK, VagiQUICK, MenoQUICK, GlutenCHECK, Heli-C-CHECK, FerritinCHECK, FOBCHECK, Alkohol Test and DrugTEST brands. The company was founded by Olaf Stiller in 2006 and is headquartered in Marburg, Germany.

Ownership
‪‪12.90 M‬‬
Free Float shares
‪‪12.02 M‬‬ (93.13%)
Closely held shares
‪‪886.64 K‬‬ (6.87%)
Free Float shares
‪‪12.02 M‬‬ (93.13%)
Closely held shares
‪‪886.64 K‬‬ (6.87%)
Capital structure
No data available
There's currently no data to show about this capital structure.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪17.36 M‬‬
Price to earning ratio (P/E)
Price to sales ratio (P/S)
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
Price to sales ratio (P/S)
Valuation ratios
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
‪0.00‬
‪2.00‬
‪4.00‬
‪6.00‬
‪8.00‬
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪−210%‬
‪−165%‬
‪−120%‬
‪−75%‬
‪−30%‬
H2 '22
H1 '23
H2 '23
H1 '24
‪‪−4.50 M‬‬
‪0.00‬
‪‪4.50 M‬‬
‪‪9.00 M‬‬
‪‪13.50 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
No data available
There's currently no revenue data to show for the selected period.

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2023
Medical Rapid Diagnostic Products
By country
Period: 2023
Germany

Dividends

Dividend yield, history and sustainability

Dividend summary
Dividend yield TTM
0.00%
Last payment
Last ex-date
Last pay date
Dividend history
‪0%‬
‪2%‬
‪4%‬
‪6%‬
‪8%‬
2019
2020
2021
2022
2023
‪0.00‬
‪0.13‬
‪0.26‬
‪0.39‬
‪0.52‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
‪0.00‬
‪‪8.00 M‬‬
‪‪16.00 M‬‬
‪‪24.00 M‬‬
‪‪32.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
Assets
Liabilities